CD33 and CD45-positive cells were isolated from the bone marrow and spleen when animals approached the endpoint, and aITGB2 expression in the CD33/CD45-positive tumor population was analyzed using flow cytometry (Figure S22). This evidence concerns the gene CD33 and neoplasm.